LON:YGEN Yourgene Health (YGEN) Share Forecast, Price & News GBX 0.52 0.00 (0.00%) (As of 09/8/2023) Add Compare Share Share Today's Range 0.52▼ 0.5250-Day Range 0.49▼ 0.5252-Week Range 0.19▼ 5.73Volume13.15 million shsAverage Volume21.98 million shsMarket Capitalization£16.43 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsHeadlinesProfileChartCompetitorsHeadlines About Yourgene Health (LON:YGEN) StockYourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down's syndrome, Edwards' syndrome, and Patau's Syndrome in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products. The company also offers Ranger, a technology platform for sample size selection and enrichment; Elucigene DPYD assay, a PCR test to predict a patient's response to a chemotherapy treatment; and Clarigene SARS-CoV-2 CE-IVD, a PCR assay used for routine COVID-19 testing. In addition, it provides genomic services; sample preparation and analysis tools; and bioinformatics and software products, as well as extraction for DNA, RNA/miRNA, and nucleons; quantification; genotyping; gene expression; methylation; and microarray services for clinical research organizations. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. Yourgene Health Plc was incorporated in 2000 and is headquartered in Manchester, the United Kingdom.Read More YGEN Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart YGEN Stock News HeadlinesSeptember 11, 2023 | reuters.comBRIEF-Yourgene Health Announces De-listing And Cancellation Of Trading Of SharesSeptember 5, 2023 | msn.comYourgene Health releases MagBench DNA Extraction system in APAC and Middle EastSeptember 29, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.September 5, 2023 | finance.yahoo.comYourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT WorkflowsJuly 18, 2023 | finance.yahoo.comYGEN.L - Yourgene Health PlcJune 19, 2023 | finance.yahoo.comYourgene Health Presents Data Demonstrating Successful Fetal Fraction Enrichment in NIPT Workflows Following Prolonged Blood Storage in EDTA TubesJune 13, 2023 | marketwatch.comYourgene Health Sells Taiwanese Subsidiary for $4 MlnMay 22, 2023 | lse.co.ukYourgene to process tests at lab as part of MyHealthChecked Boots dealSeptember 29, 2023 | Chaikin Analytics (Ad)This Stock Could Go Up 66% or More.Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.April 28, 2023 | marketwatch.comYourgene Health FY 2023 Revenue Slipped But Beat Market ViewsJanuary 11, 2023 | marketwatch.comYourgene Health Raises Around GBP6.8 MlnDecember 22, 2022 | marketwatch.comYourgene Health 1H Pretax Loss Widens; Revises GuidanceOctober 28, 2022 | finance.yahoo.comWhat Is Yourgene Health Plc's (LON:YGEN) Share Price Doing?September 17, 2022 | yahoo.comDoes This Valuation Of Yourgene Health Plc (LON:YGEN) Imply Investors Are Overpaying?July 29, 2022 | finance.yahoo.comDoes Yourgene Health (LON:YGEN) Have A Healthy Balance Sheet?June 20, 2022 | finance.yahoo.comYourgene Health Launches LightBench Detect for Fetal Fraction EnrichmentJune 15, 2022 | nz.finance.yahoo.comFinteum: NatWest Group, BNY Mellon, Barclays and 11 Additional Banks Trial Intraday FX Swap and Repo Trading PlatformJune 14, 2022 | finance.yahoo.comShareholders in Yourgene Health (LON:YGEN) are in the red if they invested three years agoApril 26, 2022 | marketwatch.comYourgene Health's FY 2022 Revenue Soared; Chairman to Leave Amid New Restructuring ProcessApril 15, 2022 | lse.co.ukPrimary Health Properties acquires Chiswick Medical CentreMarch 16, 2022 | finance.yahoo.comYourgene Health Plc (LON:YGEN) Shares Could Be 47% Below Their Intrinsic Value EstimateJanuary 18, 2022 | lse.co.ukYourgene Health sees FY revenue, underlying EBITDA ahead of expectationsDecember 16, 2021 | finance.yahoo.comYourgene Health (LON:YGEN) shareholders have earned a 22% CAGR over the last three yearsDecember 16, 2021 | lse.co.ukTRADING UPDATES: Cohort interim loss widens, Yourgene loss narrowsDecember 14, 2021 | marketwatch.comYourgene Gets New UK Health Security Agency ContractOctober 8, 2021 | news.yahoo.comWhat Type Of Shareholders Own The Most Number of LifeSpeak Inc. (TSE:LSPK) Shares?September 16, 2021 | markets.businessinsider.comYourgene Health PLC : Re DHSC contract to support COVID-19 surge testingSee More Headlines Receive YGEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Yourgene Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolLON:YGEN CUSIPN/A CIKN/A Webwww.yourgene-health.com Phone44 16 1667 6865FaxN/AEmployees253Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.01) Trailing P/E RatioN/A Forward P/E Ratio77.52 P/E Growth9Net Income£-8,170,000.00 Net Margins-27.55% Pretax MarginN/A Return on Equity-27.06% Return on Assets-6.71% Debt Debt-to-Equity Ratio68.93 Current Ratio1.37 Quick Ratio1.17 Sales & Book Value Annual Sales£29.67 million Price / Sales0.55 Cash FlowGBX 0.34 per share Price / Cash Flow1.53 Book ValueGBX 4 per share Price / Book0.13Miscellaneous Outstanding Shares3,190,000,000Free FloatN/AMarket Cap£16.43 million OptionableNot Optionable Beta0.86 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Lyn Dafydd Rees (Age 49)CEO & Director Comp: $394kDr. Joanne Mason (Age 48)Chief Scientific Officer Comp: $192kDr. Chia-Han Chang Ph.D. (Age 47)Chief Entrepreneur & Director Comp: $123kPeter CharlesInterim Chief Financial OfficerPeter CoyneVP of Global OperationsMs. Joanne CrossDirector of MarketingMs. Wendy CoxHR DirectorMore ExecutivesKey CompetitorsVerici DxLON:VRCIProteome SciencesLON:PRMAbingdon HealthLON:ABDXgenedriveLON:GDRGENinCodeLON:GENIView All Competitors YGEN Stock - Frequently Asked Questions How have YGEN shares performed in 2023? Yourgene Health's stock was trading at GBX 0.35 on January 1st, 2023. Since then, YGEN stock has increased by 47.1% and is now trading at GBX 0.52. View the best growth stocks for 2023 here. What other stocks do shareholders of Yourgene Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Yourgene Health investors own include L'Air Liquide (AI), Cerus (CERS), Concepta PLC (CPT.L) (CPT), Alio Gold Inc. (ALO.TO) (ALO), Alamos Gold (AGI), African Gold Group (AGG), Alpha FX Group (AFX), Aminex (AEX), Agnico Eagle Mines (AEM) and Adobe (ADBE). What is Yourgene Health's stock symbol? Yourgene Health trades on the London Stock Exchange (LON) under the ticker symbol "YGEN." How do I buy shares of Yourgene Health? Shares of YGEN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Yourgene Health's stock price today? One share of YGEN stock can currently be purchased for approximately GBX 0.52. How much money does Yourgene Health make? Yourgene Health (LON:YGEN) has a market capitalization of £16.43 million and generates £29.67 million in revenue each year. The company earns £-8,170,000.00 in net income (profit) each year or GBX (0.01) on an earnings per share basis. How many employees does Yourgene Health have? The company employs 253 workers across the globe. How can I contact Yourgene Health? Yourgene Health's mailing address is Skelton House, Manchester Science Park Lloyd Street North, Manchester M15 6SH, United Kingdom. The official website for the company is www.yourgene-health.com. The company can be reached via phone at 44 16 1667 6865. This page (LON:YGEN) was last updated on 9/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yourgene Health Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.